Literature DB >> 32087035

Severe treatment-resistant acute and recurrent vesicular chronic hand eczema successfully treated with dupilumab.

Anne-Sofie Halling1,2, Claus Zachariae1,2, Jacob P Thyssen1,2.   

Abstract

Entities:  

Keywords:  case report; dupilumab; endogenous eczema; hand eczema; pompholyx

Mesh：

Substances：

Year:  2020        PMID： 32087035     DOI： 10.1111/cod.13501

Source DB:  PubMed          Journal:  Contact Dermatitis        ISSN： 0105-1873            Impact factor:   6.600


× No keyword cloud information.
  2 in total

1.  Three cases of non-atopic hyperkeratotic hand eczema treated with dupilumab.

Authors:  Laura Loman; Gilles F H Diercks; Marie L A Schuttelaar
Journal:  Contact Dermatitis       Date:  2020-10-01       Impact factor: 6.600

2.  The long-term effect of dupilumab on chronic hand eczema in patients with moderate to severe atopic dermatitis-52 week results from the Dutch BioDay Registry.

Authors:  Angelique N Voorberg; Geertruida L E Romeijn; Marjolein S de Bruin-Weller; Marie L A Schuttelaar
Journal:  Contact Dermatitis       Date:  2022-04-24       Impact factor: 6.419
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.